Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Change in Accured Expenses (2016 - 2025)

Capricor Therapeutics has reported Change in Accured Expenses over the past 15 years, most recently at $2.2 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $2.2 million for Q4 2025, up 30.61% from a year ago — trailing twelve months through Dec 2025 was $6.0 million (up 208.27% YoY), and the annual figure for FY2025 was $6.0 million, up 208.27%.
  • Change in Accured Expenses for Q4 2025 was $2.2 million at Capricor Therapeutics, up from $971647.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CAPR hit a ceiling of $2.2 million in Q4 2022 and a floor of -$541709.0 in Q4 2023.
  • Median Change in Accured Expenses over the past 5 years was $396835.0 (2021), compared with a mean of $568525.6.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 910.78% in 2023 and later surged 83134.6% in 2025.
  • Capricor Therapeutics' Change in Accured Expenses stood at $625159.0 in 2021, then skyrocketed by 257.28% to $2.2 million in 2022, then tumbled by 124.25% to -$541709.0 in 2023, then skyrocketed by 406.44% to $1.7 million in 2024, then skyrocketed by 30.61% to $2.2 million in 2025.
  • The last three reported values for Change in Accured Expenses were $2.2 million (Q4 2025), $971647.0 (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.